PP
JAZZ icon

Paloma Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Paloma Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,481
Closed -$369K – 101
2025
Q2 		$369K Buy
+3,481
New +$378K 0.05% 92
2024
Q3 		– Sell
-14,802
Closed -$1.58M – 1421
2024
Q2 		$1.58M Buy
+14,802
New +$1.63M 0.04% 399
2021
Q2 		– Sell
-5,947
Closed -$978K – 2016
2021
Q1 		$978K Buy
+5,947
New +$979K 0.02% 709
2020
Q3 		– Sell
-13,227
Closed -$1.46M – 2268
2020
Q2 		$1.46M Buy
+13,227
New +$1.46M 0.03% 756
2019
Q4 		– Sell
-5,089
Closed -$652K – 2330
2019
Q3 		$652K Sell
5,089
-13,421
-73% -$1.8M 0.01% 972
2019
Q2 		$2.64M Buy
+18,510
New +$2.49M 0.04% 319
2019
Q1 		– Sell
-9,000
Closed -$1.12M – 1807
2018
Q4 		$1.12M Buy
9,000
+7,667
+575% +$1.14M 0.03% 421
2018
Q3 		$224K Buy
+1,333
New +$229K ﹤0.01% 1346
2018
Q2 		– Sell
-3,472
Closed -$525K – 1917
2018
Q1 		$525K Sell
3,472
-3,611
-51% -$530K 0.01% 1340
2017
Q4 		$954K Buy
+7,083
New +$982K 0.01% 1056
2017
Q3 		– Sell
-4,909
Closed -$742K – 2260
2017
Q2 		$763K Buy
+4,909
New +$751K 0.01% 1332
2017
Q1 		– Sell
-19,391
Closed -$2.12M – 2104
2016
Q4 		$2.12M Buy
+19,391
New +$2.16M 0.02% 640
2016
Q3 		– Sell
-115,940
Closed -$16.4M – 1979
2016
Q2 		$16.4M Buy
+115,940
New +$17.1M 0.18% 53
2016
Q1 		– Sell
-23,082
Closed -$3.25M – 1955
2015
Q4 		$3.25M Buy
23,082
+20,013
+652% +$2.77M 0.09% 203
2015
Q3 		$407K Buy
+3,069
New +$528K 0.01% 1142
2014
Q4 		– Sell
-11,400
Closed -$1.83M – 1249
2014
Q3 		$1.83M Buy
+11,400
New +$1.75M 0.08% 237
2013
Q3 		– Sell
-82,692
Closed -$5.68M – 1057
2013
Q2 		$5.68M Buy
+82,692
New +$5.05M 0.32% 76

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Paloma Partners's JAZZ Position: Q3 2025 in Review

Paloma Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 3,481 shares — an estimated $369K sold.

Paloma Partners first reported a position in JAZZ in Q2 2013 and held it in 17 quarters. The position peaked at $16.4M in Q2 2016. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Paloma Partners reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Paloma Partners sold 3,481 Jazz Pharmaceuticals shares in Q3 2025, an estimated $369K.
  • Paloma Partners first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Paloma Partners's Jazz Pharmaceuticals position peaked at $16.4M in Q2 2016.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Paloma Partners's 13F filing for Q3 2025, filed 14 Nov 2025.